HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Takako Taniguchi Selected Research
Takako Taniguchi Research Topics
Disease
2
Infections
12/2018 - 02/2017
2
Peripheral Nervous System Diseases (PNS Diseases)
09/2012 - 05/2012
1
Starvation
02/2022
1
Mastitis
10/2021
1
Bovine Mastitis
10/2021
1
Rupture
11/2020
1
Bacteremia
02/2017
1
Neurodegenerative Diseases (Neurodegenerative Disease)
02/2016
1
Genomic Instability
02/2016
1
Genetic Translocation (Chromosomal Translocation)
02/2016
1
Bacterial Infections (Bacterial Infection)
01/2016
1
Dysbiosis
01/2016
1
Abscess
12/2015
1
Sepsis (Septicemia)
12/2015
1
Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis)
12/2015
1
Mucopolysaccharidosis I (Hurler Syndrome)
09/2013
1
Pelvic Neoplasms
09/2012
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2012
1
Glucose Intolerance
01/2012
1
Obesity
01/2012
Drug/Important Bio-Agent (IBA)
2
Anti-Bacterial Agents (Antibiotics)
IBA
10/2021 - 01/2016
2
Pregabalin (Lyrica)
FDA Link
09/2012 - 05/2012
1
Phosphates (Orthophosphate)
IBA
02/2022
1
beta-Lactamases (beta-Lactamase)
IBA
10/2021
1
Cephalosporins (Cephalosporin Antibiotics)
IBA
10/2021
1
Elastin
IBA
11/2020
1
Collagen
IBA
11/2020
1
16S Ribosomal RNA
IBA
12/2018
1
Complement System Proteins (Complement)
IBA
02/2017
1
Cytidine Deaminase
IBA
02/2016
1
Chromatin
IBA
02/2016
1
Enzymes
IBA
02/2016
1
Interleukin-1 Receptor-Associated Kinases
IBA
12/2015
1
Polysaccharides (Glycans)
IBA
09/2013
1
Heparitin Sulfate (Heparan Sulfate)
IBA
09/2013
1
Iduronidase (alpha-L-Iduronidase)
IBA
09/2013
1
Paclitaxel (Taxol)
FDA Link
Generic
09/2012
1
Doxorubicin (Adriamycin)
FDA Link
Generic
05/2012
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
05/2012
1
Prednisone (Sone)
FDA Link
Generic
05/2012
1
Rituximab (Mabthera)
FDA Link
05/2012
1
R-CHOP protocol
IBA
05/2012
1
Vincristine (Oncovin)
FDA Link
Generic
05/2012
1
Messenger RNA (mRNA)
IBA
01/2012
1
Nonesterified Fatty Acids (NEFA)
IBA
01/2012
1
DDT
IBA
01/2012
Therapy/Procedure
1
Oral Administration
02/2017
1
VAP-cyclo protocol
05/2012